Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...

Good morning and welcome to the Evercore fourth quarter 2024 and full year earnings conference call. Today's call is scheduled to last about one hour, including remarks by Evercore management and the ...

In a report released on February 7, Jonathan Chappell from Evercore ISI reiterated a Buy rating on XPO (XPO – Research Report), with a price target of $168.00. The company’s shares closed last ...

Evercore Partners Inc (NYSE:EVR) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $3.41 against a forecast of $3.04. The company also exceeded revenue ...

Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsKaty Haber - Managing Director, Investor ...